ILiAD Biotechnologies Strengthens Leadership Team With Veteran Vaccine Executives as BPZE1 Advances Toward Late-Stage Development ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on developing innovative approaches to…
BioVigil Surpasses 1 Billion Hand Hygiene Opportunities, Highlighting Continued Focus on Infection Prevention and Patient Safety BioVigil, a leading provider of automated hand hygiene monitoring and infection prevention technology, has…
ImmunityBio Appoints Global Health Leader Dr. Jim Yong Kim as Vice Chairman to Strengthen International Partnerships and Expand Global Healthcare Access ImmunityBio, Inc., a commercial-stage biotechnology company focused on developing…
ACCESS and Johnson & Johnson Announce Multi-Year Agreement to Expand Advanced Cardiac Electrophysiology Technologies in U.S. Ambulatory Surgery Centers ACCESS, through its physician-led group purchasing organization, ACCESS Group Purchasing Organization…
AbCellera Reports Positive Phase 2 Results for ABCL635, Advancing Long-Acting Non-Hormonal Treatment for Menopausal Hot Flashes AbCellera has announced encouraging top-line results from the Phase 2 portion of its ongoing…
Bruker Expands Drug Discovery Capabilities with Majority Investment in MIMETAS and Organ-on-a-Chip Technology Bruker Corporation has announced a majority investment in MIMETAS B.V., a biotechnology company specializing in organ-on-a-chip platforms…
BeOne Medicines and Revolution Medicines Announce Broad Oncology Collaboration to Advance RAS-Targeted Therapies BeOne Medicines Ltd. and Revolution Medicines, Inc. have announced a multi-part strategic collaboration aimed at expanding treatment…
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have…
Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has…
Battelle Hosts National Security Commission on Emerging Biotechnology to Highlight Ohio’s Growing Biotechnology Capabilities Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus,…
AIDS Healthcare Foundation Supports Bipartisan SUSTAIN 340B Act to Strengthen and Protect Federal Drug Discount Program AIDS Healthcare Foundation (AHF) has welcomed the introduction of draft bipartisan legislation in the…
Multicenter Study Demonstrates Superior Outcomes with equicenta® CTM for Returning Performance Horses to Work Equine Performance Labs (EPL), the company behind equicenta® CTM, has announced the publication of new peer-reviewed…